If psilocybin or LSD can reduce DMN activity, it stands to reason that it might help those patients feel better. “People get locked into these very negative loops of thinking and feeling,” says Dr. Stephen Ross, an addiction psychiatrist at NYU who led the recent study on psilocybin. “It’s possible that by deactivating these kind…
‘The strongest evidence is currently for addiction, then depression and anxiety, followed by moderate evidence for obsessive compulsive disorder (OCD),’ says Professor David Nutt, a psychiatrist and neuropsychopharmacologist I speak to for advice, and who has pioneered the research. ‘In a study we published in The Lancet, one dose of psilocybin, found in magic mushrooms,…
“We’ve been looking at half a dozen syndromes, and we’re hoping to find out who shouldn’t be microdosing as well as who should,” Fadiman told IFLScience. “For example, we’re finding some groups do not do well, predominantly people whose major symptom is anxiety.” However, as the disastrous “War on Drugs” has taught us, banning a…
“There’s no scientific reason to believe that somebody is better off being completely miserable and sober than using cannabis occasionally, or even fairly regularly, as an adult and being functional and happy and productive,” said Dr. Reiman, an unpaid consultant with High Sobriety, who added, “Using cannabis is a relatively safe practice.” “Every single treatment…
Researchers have found that there is a correlation between psychedelic microdosing and a decrease in symptoms of depression, anxiety, PTSD, Bipolar disorder and even addiction. The analogous nature of the active chemicals in drugs like LSD to serotonin, a chemical in the brain associated with happiness, is a big contributor to this, as it can…
Three years later, Ric Godfrey says he hasn’t had a single symptom of the shakes or night terror since he came back from the jungle. He’s relaxed and holding down a great job. “I’ve always been afraid that someone was out to get me, but I don’t have that fear anymore,” he says. “I still…
Evidence that psychedelic drugs may offer some benefit has caused some psychiatrists to call for a reclassification of the drugs. A reclassification would make it easier to research potential benefits of these drugs. The role of psychedelic drugs in mental health, and especially in mental health treatment, continues to be controversial. Previous research suggests some…
During… [the] tragic opioid crisis, many have written some variation of the sentence, “The war on drugs has failed.” It’s true. Decriminalizing drug use is required to solve this problem. But accompanying a policy shift will need to be a major attitude adjustment, including among us bleeding hearts…. In other words, our imposition of “help”…
Writing in Scientific Reports (13 October 2017), the researchers said the findings were the first time that psilocybin had been shown to change brain activity outside of the active treatment period The team found that depressive symptoms were significantly reduced in all patients at one week, and 47% showed a response at five weeks. There…
“Psychedelic use is associated with 27 percent reduced risk of past-year opioid dependence and 40 percent reduced risk of past-year opioid abuse. Other than marijuana use, which was associated with 55 percent reduced risk of past-year opioid abuse, no other illegal drug was associated with reduced risk of past-year opioid dependence or abuse.” Although more…
Recent Comments